journal article·2018-10-31Open access

Immunological compatibility status of placenta-derived stem cells is mediated by scaffold 3D structure

Sara Azizian, Fatemeh Khatami, Khashayar Modaresifar, Nariman Mosaffa, Habibollah Peirovi, Lobat Tayebi, Soheyl Bahrami, Heinz Redl, Hassan Niknejad

Abstract

Placenta-derived amniotic epithelial cells (AECs), a great cell source for tissue engineering and stem cell therapy, are immunologically inert in their native state; however, immunological changes in these cells after culture and differentiation have challenged their applications. The aim of this study was to investigate the effect of 2D and 3D scaffolds on human lymphocyte antigens (HLA) expression by AECs. The effect of different preparation parameters including pre-freezing time and temperature was evaluated on 3D chitosan-gelatine scaffolds properties. Evaluation of MHC class I, HLA-DR and HLA-G expression in AECs after 7 d culture on 2D bed and 3D scaffold of chitosan-gelatine showed that culture of AECs on the 2D substrate up-regulated MHC class I and HLA-DR protein markers on AECs surface and down-regulated HLA-G protein. In contrast, 3D scaffold did not increase protein expression of MHC class I and HLA-DR. Moreover, HLA-G protein expression remained unchanged in 3D culture. These results confirm that 3D scaffold can remain AECs in their native immunological state and modification of physical properties of the scaffold is a key regulator of immunological markers at the gene and protein expression levels; a strategy which circumvents rejection challenge of amniotic stem cells to be translated into the clinic.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · RNA Interference and Gene Delivery · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences

Department of Biomaterials, Faculty of Biomedical Engineering, Amirkabir University of Technology

Nanomedicine and Tissue Engineering Research Center, Shahid Beheshti University of Medical Science

Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Science

School of Dentistry, Marquette University

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Research Center

Funding

Elite Researcher Grant Committee · National Institutes

References (44)

Show source-provided references
1. 10.1038/s41598-017-17210-710.1038/s41598-017-17210-7 ↗
2. 10.22203/eCM.v015a0710.22203/eCM.v015a07 ↗
3. Mohammadi AA, Sabet B, Riazi H, et al. Human amniotic membrane dressing: an excellent method for outpatient management of burn wounds. Iran J Med Sci. 2015;34:61–64.
4. 10.1097/ICO.000000000000086710.1097/ICO.0000000000000867 ↗
5. 10.1002/term.206410.1002/term.2064 ↗
6. 10.1016/j.mehy.2014.01.03410.1016/j.mehy.2014.01.034 ↗
7. 10.1016/j.mehy.2013.08.01810.1016/j.mehy.2013.08.018 ↗
8. 10.1016/j.cryobiol.2016.12.00110.1016/j.cryobiol.2016.12.001 ↗
9. 10.1016/j.cryobiol.2015.09.00810.1016/j.cryobiol.2015.09.008 ↗
10. 10.1634/stemcells.2004-035710.1634/stemcells.2004-0357 ↗
11. Parolini O, Hess DC, Borlongan CV. Human amniotic epithelial cells and amniotic mesenchymal cells express the embruonic stem cell marker Oct-4 in vitro and promote behavioral and histological benefits when transplanted in ischemic stroke rats. J Am Heart Assoc. 2008;39:657–657.
12. 10.1016/S0198-8859(00)00192-010.1016/S0198-8859(00)00192-0 ↗
13. 10.1016/j.mehy.2015.04.03010.1016/j.mehy.2015.04.030 ↗
14. 10.1097/01.ico.0000247214.31757.5c10.1097/01.ico.0000247214.31757.5c ↗
15. 10.1007/s00441-016-2364-310.1007/s00441-016-2364-3 ↗
16. 10.1095/biolreprod.106.05524410.1095/biolreprod.106.055244 ↗
17. 10.1002/jcp.2123710.1002/jcp.21237 ↗
18. 10.1016/j.smim.2007.12.00510.1016/j.smim.2007.12.005 ↗
19. 10.1016/j.polymer.2014.06.03710.1016/j.polymer.2014.06.037 ↗
20. 10.1002/978047018583410.1002/9780470185834 ↗
21. 10.1039/C5PY00156K10.1039/C5PY00156K ↗
22. 10.1080/21691401.2017.134977810.1080/21691401.2017.1349778 ↗
23. Hoque ME, Nuge T, Yeow TK, et al. Gelatin based scaffolds for tissue engineering-a review. J Polym Res. 2015;9:15.
24. 10.1021/bm200083n10.1021/bm200083n ↗
25. 10.1080/21691401.2016.119302510.1080/21691401.2016.1193025 ↗
26. 10.1007/12_2011_11210.1007/12_2011_112 ↗
27. 10.1080/21691401.2016.120379610.1080/21691401.2016.1203796 ↗
28. 10.1016/j.ijpharm.2014.09.03610.1016/j.ijpharm.2014.09.036 ↗
29. 10.1016/j.biomaterials.2005.05.03610.1016/j.biomaterials.2005.05.036 ↗
30. 10.3109/21691401.2013.85210110.3109/21691401.2013.852101 ↗
31. 10.1021/bm034327e10.1021/bm034327e ↗
32. 10.1016/j.msec.2013.05.03910.1016/j.msec.2013.05.039 ↗
33. 10.1080/09205063.2012.73137410.1080/09205063.2012.731374 ↗
34. 10.1016/j.cryobiol.2013.05.00110.1016/j.cryobiol.2013.05.001 ↗
35. Ross DW. Current protocols in cytometry. Arch Pathol Lab Med. 1998;122:660.
36. 10.1002/smll.20110093410.1002/smll.201100934 ↗
37. 10.1016/j.tibtech.2012.03.00510.1016/j.tibtech.2012.03.005 ↗
38. 10.5772/2411810.5772/24118 ↗
39. 10.1016/S0142-9612(99)00036-810.1016/S0142-9612(99)00036-8 ↗
40. 10.2147/SCCAA.S5869610.2147/SCCAA.S58696 ↗
41. 10.1016/j.jab.2015.10.00410.1016/j.jab.2015.10.004 ↗
42. Hudson KD, Rodriguez M-A, Bonassar LJ. Differential MHC class receptor expression in in vitro human mesenchymal stem cells is mediated by scaffold material. Orlando (FL): Orthopaedic Research Society; 2016.
43. Mehrabi M, Dounighi NM, Rezayat Sorkhabadi SM, et al. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant. Artif Cells Nanomed Biotechnol. 2017;43:124–132.
44. 10.1016/j.polymer.2013.01.00410.1016/j.polymer.2013.01.004 ↗